Your session is about to expire
← Back to Search
Curcumin + Piperine for Prostate Cancer
Study Summary
This trial will explore the use of curcumin and piperine supplementation to treat early stage prostate cancer and myeloma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My MGUS or SMM diagnosis follows international expert guidelines.I have symptoms of a rare blood disorder.I am currently taking supplements with curcumin or piperine.I have at least one risk factor indicating a high chance of my condition progressing to Multiple Myeloma.I have had major surgery or a significant injury within the last 4 weeks.I have early-stage prostate cancer and am monitoring it, or I have MGUS or low-risk SMM and am only observing it.I am 18 years old or older.I am able to care for myself but may not be able to do active work.I plan to start new over-the-counter supplements soon.My MGUS/SMM condition has been stable with no treatment needed for the past year.I am not planning any primary curative treatments like surgery or radiation for my prostate cancer.
- Group 1: Prostate Cancer
- Group 2: Smoldering Multiple Myeloma (SMM)
- Group 3: Monoclonal Gammopathy of Unknown Significance (MGUS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants does the trial have capacity to accomodate?
"Affirmative, clinicaltrials.gov lists this trial as actively enrolling patients. It was first shared on December 14th 2021 and the most up to date information is from June 17th 2022. 40 individuals are being sought out by 1 medical centre for participation in the study."
Is there any prior research to support the utilization of Curcumin plus Piperine in experimental studies?
"At the present, 17 clinical trials encompassing Curcumin plus Piperine are being conducted. Of these studies, 3 are in their final phase of testing. Although Farmington Hills is the primary location for this research, there are 21 other sites around Michigan hosting tests related to this treatment."
Is the combination of Curcumin and Piperine a safe option for treating patients?
"Our assessment of Curcumin plus Piperine's safety was a 2, since there is evidence that it does not pose significant risks; however, this Phase 2 trial has yet to reveal any efficacy data."
Is this trial currently recruiting participants?
"Correct. Clinicaltrials.gov displays that this research endeavor, which was first made available on December 14th 2021, is actively recruiting volunteers. 40 participants must be sought from one medical site."
Share this study with friends
Copy Link
Messenger